Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation
Wei Wang(Capital Medical University), Shuwen Liu(Zhengzhou University), Xiaoyan Pan(Guizhou University), Guodong Hu(Institute of Biophysics), Shasha Li(Green Chemistry), Chan Wang(Shihezi University), Shuxian Yin(Nanfang Hospital), Chan Yang, Wei Xü(Southern Medical University), Xinfeng Xu(Southern Medical University), Xiaoge Niu(Southern Medical University)
Cited by 36
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
|Nature Communications|2021|299
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
|Drug Resistance Updates|2022|257